Fingerprint
Dive into the research topics of 'Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically